Literature DB >> 26243638

Management of endocrine disease: Diabetes and osteoporosis: cause for concern?

Jakob Starup-Linde1, Peter Vestergaard2.   

Abstract

Diabetes and osteoporosis are both frequent conditions, and they may thus occur simultaneously by chance. However, a growing body of evidence suggests that hyperglycemia may impair bone matrix formation and biochemical competence. Decreased biomechanical competence may be present even in a setting of increased bone mineral density, as assessed by traditional dual energy X-ray absorptiometry or normal structural parameters by quantitative computed tomography. Also, the absence of endogenous insulin secretion in type 1 diabetes (T1D) and insulin resistance or, in some cases, frank hyperinsulinemia in T2D may play a role.
© 2015 European Society of Endocrinology.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26243638     DOI: 10.1530/EJE-15-0155

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  21 in total

1.  Bone mass loss is associated with systolic blood pressure in postmenopausal women with type 2 diabetes in Tibet: a retrospective cross-sectional study.

Authors:  L Zhou; J Song; S Yang; S Meng; X Lv; J Yue; A Mina; B Puchi; Y Geng; L Yang
Journal:  Osteoporos Int       Date:  2017-02-02       Impact factor: 4.507

Review 2.  Bone Microarchitecture in Type 1 Diabetes: It Is Complicated.

Authors:  Hillary A Keenan; Ernesto Maddaloni
Journal:  Curr Osteoporos Rep       Date:  2016-12       Impact factor: 5.096

Review 3.  Update on Bone Health in Pediatric Chronic Disease.

Authors:  Kristen M Williams
Journal:  Endocrinol Metab Clin North Am       Date:  2016-04-07       Impact factor: 4.741

4.  Risk of osteoporosis and fracture in victims with burn injury.

Authors:  O Kaewboonchoo; F C Sung; C L Lin; H C Hsu; C T Kuo
Journal:  Osteoporos Int       Date:  2019-02-08       Impact factor: 4.507

Review 5.  The New Possibilities from "Big Data" to Overlooked Associations Between Diabetes, Biochemical Parameters, Glucose Control, and Osteoporosis.

Authors:  Christian Kruse
Journal:  Curr Osteoporos Rep       Date:  2018-06       Impact factor: 5.096

Review 6.  Exposure to hypoglycemia and risk of stroke.

Authors:  Logan Smith; Diya Chakraborty; Pallab Bhattacharya; Deepaneeta Sarmah; Sebastian Koch; Kunjan R Dave
Journal:  Ann N Y Acad Sci       Date:  2018-06-19       Impact factor: 5.691

Review 7.  Falls and Fractures in Diabetes-More than Bone Fragility.

Authors:  Nicklas Højgaard Rasmussen; Jakob Dal
Journal:  Curr Osteoporos Rep       Date:  2019-06       Impact factor: 5.096

8.  The role of RANKL and FGF23 in Assessing Bone Turnover in Type 2 Diabetic Patients.

Authors:  G Niță; O Niță; A Gherasim; L I Arhire; A M Herghelegiu; L Mihalache; C Tuchilus; M Graur
Journal:  Acta Endocrinol (Buchar)       Date:  2021 Apr-Jun       Impact factor: 1.104

9.  FK506 prevented bone loss in streptozotocin-induced diabetic rats via enhancing osteogenesis and inhibiting adipogenesis.

Authors:  Li-Hua Ni; Ri-Ning Tang; Cheng Yuan; Kai-Yun Song; Li-Ting Wang; Xiao-Chen Wang; Yu-Xia Zhang; Xiao-Liang Zhang; Dong-Dong Zhu; Bi-Cheng Liu
Journal:  Ann Transl Med       Date:  2019-06

10.  Effects of Trigonelline, an Alkaloid Present in Coffee, on Diabetes-Induced Disorders in the Rat Skeletal System.

Authors:  Joanna Folwarczna; Aleksandra Janas; Maria Pytlik; Urszula Cegieła; Leszek Śliwiński; Zora Krivošíková; Kornélia Štefíková; Martin Gajdoš
Journal:  Nutrients       Date:  2016-03-02       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.